Figure 1

The expression of sIL-27Rα level in GVHD patients. (A) Serum sIL-27Rα levels were significantly increased on the day of neutrophil engraftment compared with pre-conditioning (P < 0.0001). (B) The serum sIL-27Rα levels in patients with grade II–IV aGVHD were significantly lower than those of 0-I aGVHD patients on the day of neutrophil engraftment (P < 0.001). (C) On the day of neutrophil engraftment, serum sIL-27Rα levels in patients with skin aGVHD (P < 0.01) and liver aGVHD (P < 0.05) were significantly lower than those of 0-I aGVHD patients. (D) There were no similar significant difference regarding cGVHD. Data shown are mean ± SD.